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Abstract 
Vpr， one of the accessory gene products of hUlnan unlnunodeficiency virus type 1 
(HIV-l)ラ affectsboth viral and cellular proliferationラ beinginvolved in long ten11inal 
repeat (LTR) activation， arrest of the cell cycle at the G2 phaseラandapoptosis. Recentlyラ
it was found that Vpr interacted with sp1iceosome-associated protein (SAP) 145 in a 
yeast two-hybrid screen. Since SAP145 is an essential splicing factor， itwas exan1ined 
whether Vpr c出1regulate the splicing reaction and to discover a novel role for Vpr， 
which accUlTIulates the cellular pre-lTIRNA in vivo. HoweverヲwhetherVpr interacts with 
SAP 145 in the host cells and inhibits splicing reaction directlyラareunknown. 
Here 1 addressed the n1echanisn1 of splicing inhibition by Vpr. Firstち itwas 
found that Vpr interacted with SAP 145 in vitro and in vivo. Coin1n1unoprecipitaion 
and colocalization showed that Vpr also interacts with other spliceosOlne factors and 
snRNPs. Nextラ usingin vitro splicing assayラ 1clearly confirmed that Vpr inhibits 
splicing of β'-globin pre-lnRNA directlyラ andblocks spliceosome asselnbly at the early 
stages. Furthermoreラ byusing lTIutant f01111S of Vpr with specific substitution in two 
d0111ains on Vprヲ 1dell10nstrated that the interaction between Vpr剖1dSAP145 is 
indispensable for splicing inhibition. Finally， counlTIunoprecipitation and in ¥ノitro
cOlnpetiti ve binding assay indicated that Vpr associates with SAP 145 and then 
suppresses the SAP 145-SAP49 cOlnplex fon11ation. These results suggest that cellular 
expression ofVpr n1ay trigger sp1iceosome assen1bly suppression by interfering with the 
function of SAP 145-SAP49 c01nplex in the host cells. 
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Introduction 
Acquired ituluunodeficiency syndrome (AIDS) was first reported in the United 
States in 1981 and has since bec01ue a luajor worldwide epideluic. AIDS is caused by 
the hUluan imluunodeficiency virus type 1 (HIV-l). By killing or daIuaging cells of 
the body's I1uluune systemラ HIV-1progressively destroys the body's ability to fight 
infections and celiain cancers. People diagnosed with AIDS may get life-threatening 
diseases called opportunistic infections， which are caused by microbes such as viruses 
or bacteria that usually do not make healthy people sick. 
In 1983ラ experI1uentaldata indicating an association between a retrovirus and 
AIDS were published by a research team in France led by Luc Montagnier 
(Barre-Sinoussi et al吋 1983).In 1984ラ theFrench group and researchers at the US 
National Institute of Healthラ ledby Robeli C. Galloぅ publishedsemina1 papers that 
establishedラwithviriological and epidemiological evidenceヲthatthe virus now known 
as HIV-1 was the cause of AIDS (Galloラ2002;Montagnierぅ2002).The virus was a1so 
isolated independently by Jay Levy in California企omboth individuals affected with 
AIDS and aSytupt01uic individuals企O1U groups at high risk for AIDS (Levy et al.ラ
1984). 
All retrovirus contain three luajor open reading frames， including gag (generates 
the viral core after intravi討onprocessing of a precursor polypeptide)， po! [encodes the 
Reverse transcriptase (RT)， lntegrase (IN)， and protease enzytuesJラ en1ノ (directsthe 
production of the transn1en1brane and surface glycoproteins). ln additionラ HIV-1，a 
lneluber‘ of the lentivirus subian1ily of retrovirus contain genes for regulatory (tat and 
rev) and accessory (vpr，ψU，νゲ， and ne_乃proteins(Fig. 1). If HIV-l life cycle is 
assu111ed to start at the binding to CD4+ T cel (Dalgleish etαょう 1984)or l1acr・ophageラ
F d 
the following stages are as follows. Following binding th1・oughinteractions between 
HIV-1 envelope (Env) and CD4 and CC chelnokine receptor (CCR) 5 (Alkhatib et aょう
1996) or CXC chelnokine receptor (CXCR) 4ラ EnvtranS111elnbrane region undel‘goes a 
conおnnationalchange that pr01110tes virus句cel lnelnbrane fusion， thereby allowing 
entry of a viral core into the cell. The Vlnon core is then uncoated to expose 
nucleop1・oteIncomplex where the genon1ic RNA isreverse transcribed by RT into viral 
genomic DNA. This c01nplex is called preintegration c0111plex (PIC) or reverse 
transcriptase cornplex (RTC). PIC goes through nucleapore c01nplex to the nuc]eus 
(J enkins et aょう 1998;Popov et aょう 1998;Fassati et al.ラ2003).The nuclear i111port ability 
ofthe PICうwithouta requirelnent f01" the breakdown of the nuclear envelope that occurs 
during cell divisionラ isnecessary for infection by HIV-1 of nondividing cellsラ suchas 
quiescent T lyn1phocytesラtenninallydifferentiated dendritic 111acrophages. Matrix (MA)， 
IN and Vpr have been identified as possible lnediators of the nuclear import of the PIC 
(KaInata et aょう 2005).Thenラ INcatalyzes integration of viral gen01nic DNA into host 
chr01nosOlne and the DNA isrepaired. Viral transcripts are expressed f1喝on1the pr01noter 
located in the 5' long ten11inal repeat (LTR)， with Tat greatly enhancing the rate of 
transcription. A set of spliced (Purcell and Martinヲ 1993)and genOlnic-length RNAs are 
transported frOln the nucleus to the cytoplaslnラwherethey can be translated or packaged. 
This step is regulated by Rev (PollaI・dand Malin1ラ 1998).VirallnRNAs are translated in 
the cytoplaslnう andthe Gag and Gag-Pol polyproteins becOlne localized to the cell 
111elnbranιThe Env lnRNA is translated at the endoplaslnic reticulUln (ER). The core 
particle is asselnbled frOln the Gag and Gag-Pol polyproteins [later・pr・ocessedto lnatrixラ
capsid (CA)， nucleocapsid (NC)， proteaseラRTand IN]， VifラVpr，Nef: and the genon1ic 
RNAラandan immature virion begins to bud iOln the cel surface. As the particle buds 
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and is released frOl1 the cell surface coated with Env proteinラ thevirion undergoes a 
n10rphologic change known as l11aturation. This step involves proteolytic processing of 
the Gag and Gag-Pol polyproteins by viral protease. The n1ature virion is then ready to 
infect the next cell (Frankel and Youngラ 1998).
The νpr geneラoneof the accessory genesラencodesa 96時aI11ino-acidprotein (Fig. 
2)ラwasanalyzed its three-dI111ensional structure by nuc1ear magnetic resonance (NMR) 
(Wecker et a1ラ 2003;Morel1et et aょう 2003).Vpr is highly conserved among prIl11ate 
lentiviruses， inc1uding HIV-1， HIV-乙 and Sl111an immunodeficiency virus (SIV) 
(Planelles et a1.ラ 1996)and associated with virus particles despite being a non-structural 
protein (Cohen et a1.， 1990). In addition， the incorporation of Vpr has been shown to be 
specific involving a distinct domainラ p6regionラ inGag (Lu et aょう 1995; Kondo and 
Gottlinger， 1996)ラbycontrast other accessory proteinsラVifandNefラwereincorporated 
into virひspatiic1es by a non-specific 111echanisl11 (Azadラ2000).The experiments canied 
out using SIV in rhesus macaques indicated that pathogenesis in infected luacaques was 
intluenced by Vpr in vivo (Tungatmihi et a!.ラ2003).By contrastラitappears that Vpr is 
not absolutely required for viral rep1ication because deletion of Vpr is not lethal to viral 
replication inνitro. Howeverうitwas reported that Vpr is present in significant al110unts 
in the serUl1 of HIV-1-infected patients and that it activates viral expression in latently 
infected cel1lines and resting peripheral blood mOl1onuc1ear cells (PBMC) (Levy et a1ヲ
1993 and Levy etαょう 1994).These observations suggest that Vpr is very l11uch involved 
in the life cycle of HIV-1 and controls both the replicatiol1 and pathogenesis of this virus. 
Moreoverぅ thefact that n1any copies of Vpr・arepackaged in progeny virions suggests 
that the protein 111ight play a role early in the infectious process (Cohen et aょう 1990). 
Experin1ental support for an ear1yおnctionalrole for Vpr COl11es合011observations of a 
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contribution by Vpr to the nuc1ear import of provira1 DNA in l10ndividing cellsラsuchas 
n1acrophages (Heinzinger etαl叶 1994).In additionラ Vprsynthesized de novo plays an 
additiona1 role in the replication of HIV-l because Vpr that is supplied in trans does not 
fully c0111plelnent the replication of Vpr-negative viruses in infected 11aCI・ophages
(Connor et al.ラ 1995).It i臼spossible t白ha剖tVp戸rn1百屯ght社 up戸r古egulat匂ethe expression of vira 
geむnes.These reports indicated that Vpr could play Ilnpoliant roles in HIV-l infection 
(Connor etαょう 1995)and AIDS pathogenesis. 
MoreoverラVprhas lnultiple activities in the host cells (Table 1.) such as nuclear 
localization (耳目立zingeret al.， 1994; Kan1ata and Aidaラ 2000;Iijin1a et aょう 2004;
Kalnata et aょう 2005)，regulation of transcription (Subbrarnanian et al吋 1998;Kino et aょう
2002)， apoptosis (Ayyavoo et al.う 1997;Nishizawa et al.， 2000aラb;Azun1a et al.ラ2005)，
and cel cycle arrest at G2 phase (He et a人1995;Jowett etαょう 1995;Re et aょう 1995ラ
Bartz et al.ラ 1996;Goh et alラ 1998).These向日ctionsof Vpr lnust supported by its 
physical interactions with several idenufied cellular lnolecules (Kino and Pavlalくおう
2004)， such as nucleic acids (de Rocquigny etαょう 2000)，Importinα(Popov et al， 1998; 
Kalnata et al.ラ2005)ぅNucleoporin(Fouchier et aょう 1998)ラTranscriptionfactor (TF) IIB 
CAgostini et al.ラ 1996)ぅ Proteasomalsubunit mov34 (Mahalingarn et al吋 1998)ラ
Glucocorticoid receptor (GR) type I (Kino et alう2002)ラSpl(Wang etα1.ラ 1995)ぅUraci1
DNA glycosy1ase (UDG) (Bouhamdan et aょう 1996)ぅ p300(Felzien et al.ヲ 1998) and 
14-3-3 (Kino et aょう 2005) (Table 2)， though the molecu1ar lnechanislns between 
function and Vpr associated-cellular lnolecule are stil not clear. 
Pre-lnRNA splicingラ therelnova1 of non-coding introns ti'oln InRNA precursorsラ
is a pre-requisite for the expression of lnost eukaryotic genes. This essential reaction 
was carried out in the nucleus. The pre四lnRNAsplicing machinery consists 01' 1'ive slnall 
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nuclear ribonucleoproteins pmiicles (snRNPs) such as U1， U2ヲ U4ヲ U5and U6 and 
lnore than fifty proteins (Hastings and Krainer， 2001). During splicing， successive 
recognition of splice sites occurs as spliceosomal complex EラA，BラandC asselnble on 
pre回lnRNAin a stepwise lnanner (Fig. 3). 1n the cOlnmitment complex EラU1snRNP 
is bound to the 5' splice site and splicing factors U2AF and SF1 are attached to the 
polypyri1nidine tract upstremn of the 3' splice site and the branch siteラrespectively. As 
U2 snRNP binds to the branch siteラ cOlnplexE is converted to presplicing c01nplex A 
(Gozani et aょう 1996)， a ShOl1 helix forms between a single-stranded region in U2 
snRNA and the intron branch site which requires both the 12S snRNP and splicing 
factors (SF) 3a and SF3bラwhichcontain subunits of SF3a60うSF3a66うandSF3a120ヲor
SF3b10， SF3b14bヲ p14ラ spliceosome-associatedprotein (SAP) 49ヲ SAP130ラ SAP145
and SAP 155， respectively (Wells etα1.ラ 1996;Das et al.， 1999; Will et al.ラ 2001).Next 
step is binding of the U4/U5/U6 tri-snRNP at the 5' splice site to form the B c01nplex. 
J ust prior to splicingラ confonnationalchanges within cOlnplex B destabilize the 
association of U 1 and U4 snRNPs and transfonn cOlnplex B into cOITlplex C (Fig. 3). 
SAP145ラ anessential component of the SF3b subunit in U2 snRNPラ canbind to 
pre-lnRNA (Staknis and Reedラ 1994)and is ill1plicated in the tethering of U2 snRNP to 
the branch point site that is required for cOll1plex A assen1bly (Champion-Arnaud and 
Reed， 1994). SAP49 has two RNA recognition lnotifs (RRMs) that are located on the 
surface of SF3b (Golas et al.ラ2003)ラandinteracts directly and highly speci五callywith 
both SAP145 and pre-lnRNA. Thusラtheobservation that SAP 145 and SAP49 interact 
directly with both U2 snRNP and the PI・e-lnRNAsuggests that this protein con1plex 
plays an in1portant role 1n tethering U2 snRNP to the branch site (Gozani et aょう 1996).
Sever・alviral proteins have also been shown to regulate the splicing of cellular 
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pre-lnRNAs. For exanlp1e， the Herpes Simp1ex Virus type 1 (HSV-1) ICP27 protein has 
a1so been reported to inhibit splicing through its association with SAP 145 and to 
interact with SRPKl resulting in hypophosphorylation of serine-and arginine-rich (SR) 
proteinsラ whichI1npairs their r01es in spliceosonle assenlbly (Bryant et al.， 2001; 
Lindberg et al.， 2002; Sciabica et al.， 2003; Snlith et al.， 2005). NS 1， an in白uenzaVlrus 
non-structural proteinラ inhibitsthe splicing of the nlajor class of ln31nn1alian 
pre-n1RNAs (GU-AU introns) by binding to a specific stem-bulge in U6 snRNAラ
thereby blocking the fonnation of U4/U6 and U2/U6 conlplexes (Folies et a!.ラ 1994;Lu 
et al.ラ 1994;Qiu etα1.， 1995). HIV-l proteins Tatヲwhichacts as a transactivator of viral 
and cel1ular geneヲandRev， which is essential for nuclear export of incOlnpletely spliced 
viral mRNAsラ havealso been shown to inhibit HIV-l splicing by the interaction wi th 
p32ラacofactor of ASF/SF2 (Be町oet al.ヲ2006;Powel1 et al.， 1997)ラhowever，whether 
HIV-1 protein regulates splicing of cellular pre-lnRNA， but not viral pre-lnRN Aラ are
unknown. 
Recently.ラ itwas found that Vpr interacted with SAP 145 in a yeast two-hybrid 
screen (Zhang et al.ラ personalcOlnmunication). Since SAP 145 is an essential splicing 
factorラitwas exalnined whether Vpr can regulate the splicing reaction and discovered a 
novel role for Vpr， which accU1nulatesα-globin 2 andβ'-globin pre-lnRNA in viνo 
(Kuranlitsu et aょう 2005).It was also indicated strong evidence that Vpr expressed fron1 
an HIV-l provirus was sufficient to accumulate for α-globin2 pre-mRNA (KurmTIitsu et 
α1.ラ2005).
The lnain aim of this thesis is to delTIOnstrate that regulatory and lTIolecular 
lnechanisms of splicing inhibition of the cellular pre-lnRNA by Vpr・.Firstlyラ1confinl1ed 
that Vpr interacted wIth SAP145 in a pull-down assayぅ cOIlnlTIunoprecipitationand 
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colocalization. Vpr a1so colocalized with SC35ヲ awell-known sphCeOSOl11e l11arker. 
These results showed that Vpr interacts with SAP 145 and exists in the spliceosome. 
Nextラ toconfin11 that whether Vpr directly acts on splicing inhibitionラ 1eXaI11ined 
splicing assay in vitro. Although l1y previous study showed that Vpr accul11u1ates the 
cellular pre-nlRNA inνiνo (Kurarnitsu et al.ラ2005)，it was possib1e that the expression 
of Vprラ whichact as a regulator of transcription (Agostini etα1.ラ 1996;Felzien et al.ヲ
1998; Subbral11anian et al.; Kino etαょう 2002)，lnay affect the transcription of several 
genes such as SR protein and heterogeneous nuclear ribonucleoprotein (hnRNP) which 
are essential for the splicing regulation. Thereforeヲbyusing in 1ノitrosplicing assayヲ it
was clearly shown that Vpr inhibitsβ'-globin pre-mRNA splicing. By native gel 
electrophoresis analysis for in vitro splicing assayラitwas unable to五ndthe fonnation of 
complex B and C of spliceosOlne when Vpr is present. These results indicated that Vpr 
inhibits sp1icing reaction directly by blocking the early stages of spliceoSOl11e assel11b1y. 
Furthenlloreラbyusing ll1utant fonns of Vpr with specific substitution in thirdα“helical 
d01nain and arginine-rich region， 1 demonstrated that the Interaction between Vpr and 
SAP 145 was indispensable for splicing inhibition by Vpl・ Finally，
cOIlnlnunoprecipitation and in vitro cOlnpetitive binding assay showed that Vpr 
associates with SAP 145 and subsequently suppresses the SAP 145-SAP49 cOlnplex 
fonnation. The evidence suggests that theおnctionof SAP 145-SAP49 conlplex nlight 
be inhibited by Vpr when Vpl・localizesin the U2 snRNPラandthen the splicing reaction 
is inhibited. My results reveal an understanding of the lnolecular 111echanis111s of 
splicing regulation by Vpr and a novel lnechanism of Vpr at the early stage of the 
splicing assenlbly. 
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Materials and Methods 
Cellsヲtransfectionand extraction of RNA and DNA. HU1uan cervical HeLa-S3 
cells were grown in n11nln1UlU essential ll1ediulU eagle (S-MEM) (Sign1aラ St.Louisラ
MO.) supplemented with 5% heat-inactivated calf serU1U (Invitrogen， Carlsbadヲ CA.).
HU1nan cervical HeLa cells were grown in Dullヲecco'smodified Eagle's I1ediuI1  
(SigIua) that contained 100/0 heat町inactivatedfetal bovine serumぅ50units/n1 penicil1in， 
and 50μg/n11 streptoll1ycin. 
Transfections were performed by electroporation in a 4-1um-dian1eter cuvette 
using a Gene Pulser (Bio-Rad， RichluondラCA.)at 300 V and 975 ~F for HeLa cells. 
Genon1ic DNA was extracted fr01u HeLa cells with a Wizard™ gen01nic DNA 
pU1ification kit (Pr01uegaラMadisonラWI.). Total RNA was extracted企011HeLa cells 
using TRlz01™ reagent (lnvitrogen). 
Construction of plasmids. The derivative of the expression vector pME 18Neo that 
encodes Flag-tagged wild四typeVprヲ namely，pME18Neo-FVprラ hasbeen described 
previously (Nishino etαょう 1997; N ishizawa etα1.， 1999). To generate the cloning 
plasmid for the s-globin gene， including three exons and two intronsラ byPCR with 
gen01uic DNA fr01n HeLa cells as telupl乱te and prI1uers sG-I-Eco RV-5' 
(51-GGCGATATCCATGGTGCACCTGACTCCT-3') and sG-end-Xba 1-31 
(5'-GCTCTAGATTAGTGATACTTGTGGGC-3'). Then 1 cloned the aIllplified 
fraglllent between the EcoRV and XbaI sites of pBluescript I (SK+) (pSK) (Stratageneラ
La Jollaヲ CA.). The resu1ting construct was designated pSK-s-globin. The DNA 
fragI11ent encoding U 1 snRNA or U2 snRNA was obtained by PCR using total genOllic 
DNA from HeLa cel1s as teluplate as ten1plate and the prIlllers for U 1 snRNAラ Uトトデ:
デー ATACTTACCTGGCAGGGG-3ラ and U] -end-γ: 
12 
5 '-CAGGGGAAAGCGCGAACG-3'， and for U2 snRNA U2-1-5': 
デー ATCGCTTCTCGGCCTTTT四3'， and U2-end-3ヲ: 5ラ"
GGGTGCACCGTTCCTGGA-3' were usedヲ andwas Inserted Into pSKラ designated
pSK-Ul or pSK目U2respectively. To generate the c10ning plaslnid pSK/SAP 145ラ
containing hmnan SAP 145 cDNA was mnplified by PCR with HeLa cDNA as tenlplate 
and the prIlnersラ 5' -Bgl II/SAP145: デー CAGGAGATCTGTCTGATGAG-3ヲ and 
SAP 145/5' -stop-3ラ: 5'-CAAGTTTTAGGTCCCCTCACACTAGC-γ. The productラC
terminal side of SAP 145う wasc10ned between BgI I and Sma 1 sites of the pSK. N 
tenl1inal side of hUlnan SAP145 cDNA was mnplified by PCR with HeLa cDNA as 
tenlplate and the prllnersラ デー SAP145 (EcoRV): 
5' -GGCGATATCCGCGCCTGGGGCTGCCC-3'， and SAP145/3'-Bgl I: 
デー CTTAGCTCATCAGACAGATCTCCTGG目3'.The product was inserted between 
Eco RV and BgI I sites of the pSKlC tenninal side of SAP145. The c10ned plaslnid 
nanled pSKJSAP145NC. The 5ラendof hmnan SAP145 cDNA was mnplified by PCR 
with HeLa cDNA as telnplate and the primers: SAP 145-AKM-5' 
GCGATATCCGCTAAGATGGCGACGGAG and SAP145-XhoI-γ: 
CTACTCGAGGACCCAGAGG. The product was cloned Eco RV site of the pSK +.
pSK/SAP 145NC was digested with Not 1 followed by blunting and was digested Xho I.
The ti'agnlent subcloned into pSKl5ラendof SAP145， was digested with Kpn 1 followed 
by blunting and was digested Xho 1. To generate the cloning plaslnid pSK/SAP49ラ
containing hunlan SAP49 cDNA was mnplified by PCR with HeLa cDNA as telnplate 
and the primers: SAP49-2-EcoRV: 5' -GAGATATCTGCTGCCGGGCCGATCTCC-γ 
and SAP49Notl: デー GAGCGGCCGCTTACTGAGGGAGAGGGCC-γ.The product 
was cloned Eco RV and Not 1 site of the pSK +.To generate the Vpr substitution nlutants 
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designated R80Aラ R88Aぅ L67P/R80Aand L67P/R88Aラ 1introduced site-specific 
lnutations into pSK-Fvpr (Nishizawa etαょう 1999) by ExSite PCR-based site-directed 
111utagenesis using a kit f1-OIl Stratagene. Arg was changed to Ala codon by accurate 
PCR with pSK-Fvpr as the telnplate for R80A and又88Aラ pSK-L67P/Vpras the 
ten1plate for L67P/R80A and L67P/R88A and the following prIlners: 
5' -AATAGGCGTTACTCGACAGA-3' and 5' -GCGCTATGTCGACACCCAAT-γfor 
R80A; 5' -AGCAAGAAATGGAGCCAGTA同γand
5' -GCCCTCTGTCGAGTAACGCC-3'おrR88A. Each Xho I-Not 1 ti-agmentラincluding
the site-lTIutatedνpr gene and Flag sequencesぅinpSK-Fvpr was excised and subcloned 
into pME 18Neo. pGEX-5X3-Vpr was a kind gift fi・on1Dr. K. Fujinaga (Hokkaido 
Universityラ Japan). All constructs described above were verified by nucleotide 
sequenclng. 
ln vitro splicing assay. The pSK-s-globin plasmid was linearized with BamH 1， 
and then transcribed by the Riboprobe systen1 (Prolllega) with T7 RNA polytneraseラ
71nG(ppp)G RNA Cap Structure Analog (New England 8iolabsラ 1pswichラ MA.)and 50 
μCi [a_32PJ CTP (PerkinEhnerぅWel1esleyぅMA.). Splicing reactions were canied out as 
described previously (Mayeda and Krainer， 1999). 1n brief， approxunately 25 finol of 
RNA transcript were incubated for 2 h at300C with 600/0 (v/v) nuclear extract in 
Dignam's buffer D with 20 mM creatine phosphateラ 31nM MgChラ 0.8lnM ATPラ and
2.60/0 (w/v) polyvinyl alcohol. HeLa nuclear extracts were prepared basically as 
described previously (Dignmn et al叶 1983;Lee and Greenヲ 1990). Transcripts were 
separated on a 70/0 polyacrylmnide-7 M urea denaturing gel which was exposed to an 
Ilnaging plate. 
lmmunoprecipitation and Western blotting. Following transfectionゥ cellswere 
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lysed at 40C in CHAPS lysis buffer as described previously (Kmnata and Aida， 2000) 
and subjected to Ilnlnunoprecipitations with anti-FLAG lnouse M2 MAb (SigJna) or 
anti-SAP145 sermnラ which was raised against the SAP 145 peptide sequenceラ
CPSVGPKIPQALEKILQLKE. The I1nlnunoprecipitates were applied to SDS-PAGE (8 
or 15% polyacrylan1ide). The separated proteins were transferred to a polyvinylidene 
dif1uor・idelnelnbrane (IInlnobilon; Mil1iporιBedfordラ MA.)for analysis by Westem 
blotting. Each lnelnbrane was blocked for 1 h ina solution of 50/0 (w/v) skI1n lnilk 
powder in PBS prior to incubation with FLAG-specific lnonoclonal antibody (M2ラ
SigIna)ラ anti-SAP145 serU1n or anti-SAP49 donkey polyclonal antibodies (Santa Cruz 
Biotechnologyラ Inc.，Santa Cruzラ CA.). Then the me1nbrane was incubated with 
horseradish peroxidase-linked sheep antibodies against mouseラ rabbitor donkeyラ IgG
(An1ershmn Biosciencesラ Uppsalaラ Sweden).Bands of im1nunoreactive proteins were 
detected with the SuperSignal™ West Pico chemiluminescent substrate (Pierceラ
Rockfordヲ11.)• 
Imnlunofluorescence assay. HeLa cellsラgrowingon coverslipsラwereeXa1nined 48 h 
a立eI・transfectionby an in11nunotluOl・esenceassayぅasdescribed previously (Ka1nata and 
Aidaラ2000).
GST pull-down assay. GST pul口1do¥羽W九ν1日1assays we釘repe町r壬tおonτnedby cω01口nη1bini川口lng
glut凶at出hiぬone-白Sepha担rひose4B beads-七oundGST 0αr GST-べVp戸rp戸1'0はte白inswith 1 0 ~ドμd _)コS-labeled
SAP145 p戸rot印einsfi-011 in vitlり trans1ationusing the TNT systen1 (PrOllega)ラ as
described previously (Iijilna et alラ2004;Ka1nata etα1.ラ2005).
Northern blot analysis. After incubation at 300C for 10 11inラ thesplicing 1'eaction 
was added to 2.5 nn101 of GST or GS工-Vpr and this lnixture was added 
Glutathione-Sepharose 4FF beads， as described previously (Lu et aょう 1994).RNA vvere 
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extracted with ISOGEN (Nippon geneラ TOya11aう Japan) 企011 the RNA -protein 
con1plexesラ rel11ained binding to the beadsラ and then separated on 10 0/0 
polyacrylan1ide-7孔1urea denaturing gels and transferred on a Hybond N+ (An1ersha11 
biosciences). The l11en1brane was hybridized with digoxigenin (DIG)-containing 
riboprobes specific for the U1 or U2 snRNAs， synthesized fr011 pSK-U 1 or U2. U 
snRNAs on the n1en1brene were detected by DIG Nothern Starter Kit (Roche Diagnoticsラ
IndianapolisラIN.).
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Results 
Vpr inieracts with the essential splicing factor SAP145 
Recentlyう itwas found that Vpr interacted with SAP145 in a yeast two-hybrid 
screen (Zhang et aょう personalCOlUluunication). To con白nuthe interaction between Vpr 
and SAP 145 in vitroう1perfonued GST-pull down assay. As shown in Fig. 4AラGST-Vpr
(lanes 3-5)ラbutnot GST alone (lane 2)ぅboundto in vitro translated 35S-1abeled SAP 145 
on a dose dependent luannerラ indicatingthat Vpr directly interacts with SAP 145. To 
confinu whether Vpr associates with SAP 145 U7 viν0， cellu1ar extracts from HeLa cells 
transfected with pME 18Neo-FVpr or without plasmid (Mock) were subjected to 
iluluunoprecipitation with anti-Flag M2 恥lAb and anti-SAP145 serUlU. The 
i111111unoprecipitated proteins were analyzed by Western blotting using an anti-Flag M2 
MAb (Fig. 4B). The Western blots demonstrated that Vpr cOIlulTIunoprecipitated with 
SAP145ラ inconsistent with the in vitro binding resu1ts. By contrastラ nospecific band 
was observed in the analysis using extracts irOlTI HeLa cel1s transfected without plaSlTIid 
(Fig. 4B). To exan1ine whether Vpr colocalizes with SAP 145 in the nucleusラ a
Flag-tagged Vpr expression plasn1id was transfected into HeLa cellsうandsubsequently 
IlulTIunostained with anti-Flag M2 MAb (Fig. 5う leftpanel) and anti“SAP 145 antibody 
(Fig. 5ラ luiddlepanel). Vpr was localized predOluinantly in the nuc1eus and nuclear 
envelope. By contrastぅendogenousSAP 145 was localized in the nucleus and showed a 
speckled distribution. Interestinglyラ itis clearly shown that a part of Vpr colocalizes 
with endogenous SAP 145 in a specked distribution (Fig. 5ぅrightpanel). These results 
confinued that Vpr interacts with SAP 145 in the nucleus. 
Vpr localizes in the spliceosome 
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To exan1ine the interaction between Vpr and functional spliceoso111al cOlnplexesラi
exan1ined whether Vpr were cOIlnn1unoprecipitated with SAP49， which is a con1ponent 
of U2 snRNP and binds to SAP145 directly (Chall1pion-An1aud and Reedラ 1994)，
Uト70Kヲwhichis a COlnpOnent of U] snRNP and U2Bぺwhichis a con1ponent of U2 
snRNP. As indicated in Fig. 6ラ Westernblotting of the iml11unoprecipitates with anti目
Uト70Kand U2B" clearly showed that they interacted with Vpr as well as SAP 145. 
HoweverうSAP49did not interact with Vpr. 
Nextラ tocon日nl1whether Vpr was associated with the spliceoson1es that were 
fon11edぢasplicing reaction containing the GST-Vpr protein was incubated for ] 0 lnin at 
300Cラ andthe reaction lnixture was then subjected to GST pull down. If the GST-Vpr・
becan1e associated with the spliceosOlnesラ thea註inityselection should yield the 
snRNAs that participated in splicing. The precipitated RNAs were extracted and 
analyzed by Northell1 blotting using digoxigenin-labeled riboprobes directed against U 1 
or U2 snRNA (Fig. 7). Although only the background 3lnounts of the U 1 and U2 
snRNAs were found in the reactions containing any of the GST aloneラ bandsof 
GST-Vpr were greater observed than that in GST aloneう indicatingthat GST-Vpr was 
associated with U 1 and U2 snRNP. Moreoverラ 1detennined whether Vpr colocalized 
with SC35ヲ whichwas a non-snRNP splicing factor of the SR falnily of pr・oteInsthat 
was cOffilnonly used to de五nesplicing n立clearspeckles (L31nond and Spector， 2003). 
Smne as Fig. 5ぅinthe lnerge panel (Fig. 8ラrightpanel) showed that Vpr・wascolocalized 
with endogenous SC35ラsuggestingthat Vpr localizes in the spliceosOlne (Fig. 8). 
Collectivelyラ lnyresults strongly suggested that Vpr is associated with SAP 145 
in the spliceos01ne. 
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V pr directly inhibits splicing reactions 
1n the previous studyぅ itwas appeared that Vpr caused the accU11ulation of 
inc0111pletely spliced fOn11S of a-globin 2 and β-globin pre句mRNAsin cells that had 
been transiently transfected with a Vpr expression vector (KUraI11itsu et al吋 2005).To 
detennine whether Vpr directly inhibits splicing reactionラ 1firstly prepared the 
splicing-c0111petent nuc1ear extracts (NE) f1'011 HeLa-S3 cellsラ mixedthel11 wi th NE 
prepared fr011 HeLa cel1s transfected with pME18Neo-FVpr and iml11ediately analyzed 
the splicing activity of NE onβ'-globin pre四mRNAsubstrate. As shown in Fig. 9ラ
β'-globin PI・e-mRNAwas efficiently spliced in NE fr011 HeLa-S3 by addition of 
ATP/creatine phosphate (1ane 2). 1nterestinglyラafterthe addition of Vpr-containing NEラ
the splicing was decreased by approximately 800/0 compared to that achieved by NE 
fr011 HeLa-S3 only (lane 8). The inhibition was showed 01 a dose-dependent l11anner 
(lanes 6-8). This in vitro splicing assay demonstrated that Vp1' targets splicing directly 
and inhibits it. 
Vpr inhibits splicing at the early stages of spliceosome assembly 
Assel11bly of a catalytical1y active n1etazoan spliceos0111e sequentially proceeds 
through a series of inten11ediate cornplexes ten11ed heterogeneous (H)， Eラ AぅBぅ andC 
(Fig. 3)ラ whichcan be distinguished in vitro by separating splicing reactions uSlng 
native gel electrophoresis. As shown in Fig. 10ラ whenβ'-globinp吟 n1RNAused as 
substrateラ con1plexesH十巳 Aand B十Cwere detected in addition of nuclear extracts 
fron1 Mock (lanes 1-3). E complex is hidden within the nonspecific H complex and can 
therefore 10t be distinguished using this assay. 1n contrastラ while E and A 
prespliceoso111e c0111plexes were evident in addition of Vpr-containing NEラ 11ig11cr
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C0111plexes B and C representingおnctionalspliceOSOlneS were not seen (lanes 4-6). 
These results indicate that when Vpr was present， splicing is inhibited because 
spliceosOl11e assen1bly is intenupted before the cOl11plexes B and C fonned. 
Vpr inhibits splicing of P-globin pre-mRNA via interaction with SAP145 
1n the previous study (Kur3111itsu etα1.， personal comlllunication)， the dOl11ain(s) 
involved in splicing inhibition of Vpr， was identified by producing pEGFP-N1 that 
encoded chin1eric FLAG-GFP fusion proteins that consisted of three putative structural 
regio11s 01 the basis of the an1ino acid sequence and anal ysis of three din1entional 
structure of the Vpr utilizing nuclear magnetic resonance (Wecker et aょう 2003):i) the 
五日tα-helicalregionう extendingfr01n aa 17 to aa 33 (α-H 1); i) the thirdα-helical 
reglOnラextendingfrom aa 56 to aa 77 (αH3); and ii) the arginine-rich carboxyぺel・minal
d 011 ai 1合on1aa 77 to aa 96 (77-96) (Fig. 1). This study showed that bothαH3 and 
77 -96 are indispensable for the accU11ulation of α-globin2 pre-l11RNA by Vpr. 
To verify that the interaction with SAP 145 is necessary for splicing inhibition by 
Vpl二1created 111utant f01111S of Vpr. To modify the structure and interaction ability of 
Vpr， 1 took paliicular note of L67ラ R80and R88 residues of Vpr because the previous 
study suggested thatαH3 and arginine rich region of Vpr are necessary for the splicing 
inhibition by Vpr (Fig. 11). Thusラ itwas designated point l11utations of Vpr as L67Pヲ
R80A， R88Aラ L67P/R80Aand L67P/R88A (Fig. 12). Although three 111utantsラ L67P，
L67P/R80A and L67P/R88A were ren1arkably impaired the abilities to interact with 
SAP145 (Fig. 13). 1n particularラ doublepoint 11utantsラ L67P/R80Aand L67P/R88A， 
were more severely I111paired that c0111pared with single point 111utant L67P. These 
l11utants partially restored the splicing reaction by in vitro splicing assay with substrate 
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ofβ'-globin pl・e-n1RNA(Fig. 14). By contrast， the R80A and R88A had kept activities to 
interact with SAP145 and inhibited the splicing reaction. These results indicated that the 
interaction between Vpr and SAP 145 is required for splicing inhibition of s-globin 
pl・e-lnRNAby Vpr. 
Vpr alters the interaction between SAP145 and SAP49 
Splicing factor SAP49 interacts directly and highly specifically with both 
SAP145 and pre-lnRNA and the SAP49-SAP145 complex directly interact with both U2 
snRNP and the pre-mRNA (Chalnpion-Arnaud and Reedラ 1994). To firstly verify the 
c仕fectof Vpr on SAP 145-SAP49 complex fonnationラcellularextracts froln HeLa cells 
transfected with pME18Neo-FVpr or with control vector pME18Neo were subjected to 
unlllunoprecipitation with anti-FLAG M2 MAb or anti-SAP 145 serUlllラ andthe 
resulting Ilnlnunoprecipitates were subjected to the Westem blot with anti-SAP49 serUln 
(Fig. 15A). Smne as Fig. 6ヲ inthe iml11unoprecipitation analysis with anti-FLAG M2 
MAb， the interaction between SAP49 and Vpr ¥vas not detected. SAP 145 was 
coimn1unoprecipitated with SAP49 in the control extractsラindicatingthat both proteins 
fon11 in a tight con1plex. In contrastラ theexpression of Vpr was inhibited the con1plex 
fonnation. 
To further detine how the Vpr interaction with SAP 145 inhibits SAP 145-SAP49 
comp]ex fon11ation， 1 examined to see if 111utants L67Pラ L67P/R80Aand L67P/R88A， 
which show reduced interaction with SAP 145ラ were pro五cient for inhibiting 
SAP 145-SAP49 cOlnplex fon11ation (Fig. 15B) compared to the mutants R80A and 
R88A. 1n the presence of Vpr wild typeラ R80Aand R88Aラ 1observed less 
co 1 mn1unopl・ecipitationof SAP 145 and SAP49ラbutit appeared that the intensity of the 
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band of SAP49 in presence of wild type Vpr and the R80A 111utant. 1n contrastラSAP145
and SAP49 interacted efficiently together in the presence of L67Pラ L67P /R80A or 
L67P /R88A. These results suggest that Vpr associates with SAP 145 and then suppresses 
the SAP 145-SAP49 cOlnplex fOlmation. 
To next detenl1ine whether Vpr c0111petitively inhibits the interaction between 
SAP 145 and SAP49ラ j)S-labeledin vitro translated SAP49ラ non-labeledSAP145 and 
GST-Vpr protein were lnixed and Il11111unopr・ecipitatedwith antI-SAP 145 serUll1 and 
protei口A-Sepharose.1mlnunoprecipitated proteins were analyzed by SDS-PAGE. As 
shown in Fig. 16ラthearnount of SAP49 that bound to SAP 145 decreased as a function 
of the aI110unt of GSTベlpl・.This was not the case for the control using increasing 
an10unts of GST aloneラ suggestingthat Vpr C0111petes for the interaction between 
SAP145 and SAP49. 
Col1ectivelyラ theseresults strongly indicate that Vpr cOll1petes with SAP49 for 
interaction with SAP145. 
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Discussion 
At the beginning of this studyラ 1expected that SAP 145 was one of the candidates 
fo1' Vpr-interacting proteinヲ sinceit has found that Vpr interacted with SAP 145 in a 
yeast two-hybrid screen (Zhang etα1.， personal cOl11111unication). ln l1y studyぅ 1firstly 
con五rnledthat Vpr interacts with SAP145 in vitro and inνivo (Fig. 4)ヲ andVpr was 
colocalized with SAP 145 in the nucleusラ indicatingthe SAP 145 is a Vpr-interacting 
protein in the host cells. Moreoverぅ 1found that Vpr was associated with U2Bヘa
con1ponent of U2 snRNPラUl-70Kラac0111ponent of U 1 snRNP (Fig. 6)ラandUl and U2 
sn1ミNP(Fig. 7)ラ andcolocalized with SC35ラ awelトknownspliceosol11e l11arkerラ
suggesting Vpr interacts with SAP 145 in the spliceosome. 
Since SAP 145 is an essential splicing factorラ ithas been exal11ined whether Vpr 
can regulate the sp1icing reaction and discovered a novel 1'ole fo1' Vpr， which 
accu1l1ulates αωglobin 2 and s-globin pre-l11RNA in νivo (Kurall1itsu etαょう 2005). 
Moreover， ithas been a1so indicated stro口gevidence that Vpr expressed fr011 an HIV-l 
provirus was sufficient to accUl11ulate fo1' αωglohin2 p1'e-l11RNA. However・ラ it is possible 
that the expression of Vprラ whichacts as a re忠11ato1'of tranSCI匂tion(Agostini etα1.ラ
1996; Felzien etαょう 1998;Subbrmnanian etαょう 1998; Kino etα1.ラ2002)，111ay affect the 
transcription of several genes such as SR protein and hnRNP which are essential for the 
splicing regulation in the transfected cells. Thusラ β句globinpre-mRNA substrate was 
incubated under in vitro splicing conditions in NE pr右paredfrom Vpr-expressing cells 
(Fig. 9). By in vitro splicing assaysラ 1COl1日ロ11edthat Vpr targets splicing directly and 
inhibits it. Moreover， native gel electrophoresis analysis den1011strated that Vpr inhibits 
splicing at the ear1y stages of spliceosome assel11bly (Fig. 10). This result indicates that 
splicing factors that are involved in the initial stages of the splicing process are 
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halnpered in the presence ofVpr. 
The three-dI1nentiona1 NMR structure of the full-length Vpr showed the intact Vpr 
n101ecule a1so contains three he1icesラ whichhold around of a hydrophobic core 
constituted of LeuぅIleラ Valand ar01natic residues (Morellet et aょう 2003).This could 
exp1ain S01ne of the binding properties of Vpr with different targetsラ andthe 
n10dification of the biological activity induced by specific changes of an1Ino acids 
achieved by site-directed n1utagenesis. 1ndeedラ replacen1entof Leu residue by Pro at 
position 67 within third α-helical regionαH3 of Vpr relnarkab1y iInpaired the splicing 
inhibitionラ theinteraction with SAP 145 and the inhibition of SAP49 and SAP 145 
c01nplex fonnation (Figs. 13-15). Thusぅ n1ypresent data indicates that the third 
α-helical region and in pariicular the Leu residues at position 67， isindispensab1e for 
the splicing inhibition via an intel・actionbetween Vpr and SAP145. By contrastラ
although the arginine-rich carboxy-tenninal dOlnain 77-96 appeared to be involved in 
splicing inhibitionラ substitutionsof Arg for Ala at positions 80 and 88 within this 
don1ain have no e汀ecton the splicing inhibition and interaction with SAP 145 by Vpr. 
This clearly indicated that Arg residues at positions 80 and 88 are dispensable for the 
splicing inhibition via an interaction between Vpr and SAP 145. The NMR structure a1so 
showed that basic carboxy-tenninal dOlnain of Vpr is flexib1e and stabilized when Vpr 
interacts with its pa口ner(Morellet etαょう 2003).1n factぅR80Alnutant interacted with 
SAP 145 and completely inhibited the sp1icing reactionラ butto S01ne extent could not 
inhibit the SAP49 and SAP145 cOlnplex fonnation. By contrastラR88Aas wel1 as wild 
type Vpr impaired the SAP49 and SAP145 cOlnplex fonnation. These results suggest 
that R80A may be stabi1ized its structure by interacting with SAP 145 and SAP49 
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cOlnplex. Additionallyゥ invitro c01npetitive binding assay confinned clearly that Vpr 
cOlnpeted with SAP49 against SAP 145 (Fig. 16)ラindicatingthat Vpr and SAP49 do not 
bind to each otherぅ norcompete with each other to binding site on SAP145. In the 
presence of Vpr， the 10ss-of-interacUon between SAP 145 and SAP49 were able to 
induce splicing inhibition result in sIlnilar phenotypesラ ithas been predicted that the 
interaction between Vpr and the SAP 145-SAP49 c01nplex positively and negatively 
may relate with a splicing function of Vpr. Just during my preparation of this 
lnanuscriptヲ ithas been suggested that Vpr induces cel1 cyc1e alTestラ whichis one of 
funcbons of Vpr， by binding of SAP 145 and by interfering with the Interaction between 
SAP 145 and SAP49 (Terada and Yasudaラ2006).Thusラitis likely that the expression of 
Vpr inhibits the interaction between SAP145 and SAP49. My in vitro cOlnpetitive 
binding assay (Fig. 16) also suggested that the splicing inhibition might be carried out 
tbat Vpr cOlnpeted with SAP49 against SAP145. 
lt is unknown wby Vpr・inhibitsthe function of SAP 145-SAP49 by interfering 
wi th the interacti on between SAP 14テSAP49in the host cels. Although litle is known 
about detail function of SAP 145-SAP49 cOlnplex， there is one possible hypothesis with 
regard to its function. Recentlyうthethree-diInensional structures of SF3b (Fig. 17ラGolas
et. alラ 2003)was determined by single-paliicle electron cryon1icroscopy at a resolution 
of less than 10 angstroms and then it appeared that SAP49 has two RRMs which are 
located on the sur九ceof SF3b (Fig. 17). MoreoverラChaIl1pion-Arnaudand Reed (1994) 
had den10nstrated that SAP49 UV crosslinks to pre四n1RNAin1mediately upstrea111 of the 
branchpoint sequeηce in the pre-spliceosomal complex Aラ andラ inaddition， SAP49 
participates in direct protein-protein interactions with SAP] 45ラ suggestingthat SAP49 
and SAP 145 interact in a U2 snRNP associated c0111plex that functions to tether U2 
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snRNP to the branch site. Thereforeラ itis possible that Vpr interacts with SAP 145創1d
thel・ebyinterfel・ingfonTIation of the SAP 145-SAP49 c01TIplex that directly interacts with 
both U2 snRNP and the p問問lTIRNA.Thusラ itis like1y that this protein cOlTIplex plays a 
role in stable tethering U2 snRNP to the branch site. lndeedラlTIyin vitro splicing assays 
(Fig. 9) and native gel electrophoresis (Fig. 10) indicate that authentic B and C 
c01TIplexes were not fon11ed when Vpr is presentラandthat c0111plexes A and B tra11sition 
was very inefficient in nuclear extract fro11 that transiently expressed Vpr. Likewiseラ
HSV-l protein ICP27 has been reported to interact with SAP 145 and inhibit splicing at 
the earl y stage of the splicing process (Bryant et al.， 2001， SlTIith et aょう 2005).Thu丸11y
present results indicate that the direct binding between SAP 145 and SAP49， and in 
consequenιeラ stabletethering U2 snRNP to the branch site requires f01・Bc0111plex 
spliceoson1e assen1bly on pr・e-lnRNAand the expression of Vpr inhibit its asse111bly. 
Therefore 1 propose a p立tativelTIodel for splicing inhibition by Vpr (Fig. 18). This also 
is the 五rstreport showing that an HIV-1 accessory proteinラ Vp1・ラ regulates directl y the 
cellular pre-lTIRNA splicing. My results reveal an understanding of the splicing 
regulatory and lTIolecular mechanislTI by Vpr・anda novel role of the viral protein in the 
splicing reactions 
In addition to splicing inhibitionラ ithas been well known that Vpr has 111any 
functions in both viral and cellular proliferationラsuchas cel cycle G2 arrest (He et aょう
1995; lowett et al.ラ 1995;Re et al吋 1995)ラ apoptosis(Ayyavoo et aょう 1997;Nishizawa 
uα1.ヲ 2000a，bラ AzmTIaet al.ラ 2005)and regulation of transcription (Agostini et al.ラ
1996; Felzien et al汁 1998;Subbramanian et al.ラ 1998;Kino et aょう 2002).On the other 
handヲ severalstudies rep01ied links between splicing and cell signaling such as cell 
cycle and apoptosis (Shin and Manleyラ2004;Schwerk and Schulze-OsthofI， 2005).子or
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eXaI11pleラtheyeast P RP 17 geneラencodesa splicing factorラhasbeen identical to the cell 
division cycle CDC40 genιand it was identified the homologue of hUl11an gene (Ben 
Yehuda etαl.ラ 1998).TIA-l， an apoptosis句prOlnotingproteinラ regulatesalternative 
pre】lnRNAsplicing of theα!]Joptotic gene Fαs (Forch etαょう 2000).Thereforeラ further
study is required to define c1early the relation between Vpr splicing regulation and the 
other丘lnctions.
Recentlyラ thestrong evidence was reported that an experimental infection systel11 
which utilizes high-titered HIV-lIvesticular stomatitis virus G protein showed that Vpr 
expressed fr01n an HIV-l provirus was sufficient to accul11ulate endogenous a -globin 
2 PI・e-lnRNA(Kuralnitsu et aょう 2005)and an NL43-2-drived lnutant virus lackingνpr 
produced low level of de novo synthesized env lnRNA and Env proteinラ and
COl‘respondingly showed lower viral infectivity (Zhang etαょう personalcOl11munication). 
These repolis suggest that Vpr n1ay regulate both cellular and viral pre-l11RNA splicingラ
and play important roles in五IV-linfection and replication. While the regulation both 
cellular and HIV-l pl・c・-lnRNAsplicing relnain to beおlyelucidatedう inthis study 
del110nstrated a novel role for VpI・inthe splicing reaction. My results provide Il11portant 
insight for the design and selection of novel targets for anti-HIV-l drug developl11ent 
Collectivelぁ 1propose that the interaction between Vpr and SAP 145 and the 
splicing regulation by Vpr can be novel targets for anti-HIV-l drug development. 
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Figure 1. The structure of HIV-l genome. Al1 retrovirus contain three major open 
reading白-amesラ includinggαg (generates the viral core after intravirion processing of 
the pssgag precursor polypeptide)ぅpol(encodes the RTうINヲandprotease enz戸ηes)ぅand
eην(directs the production of the tr・ansmembraneand surface glycoprotein). In addition， 
日IV-lcontains genes for regulatory (ωt and rev) and accessory (νpr， vpu，ν民andnef> 
protelns. 
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Figure 2. Schematic representation of the Structure of Vpr identified by amino acid 
sequence analysis (A) and the three四dimensionalstructure using NMR (s). The 
structure of the protein was characterized by the defined firstα-helical d0111aIn 
extending from aa 17 to aa 33うthesecondα七elicaldOlnain extending from aa 38 to aa 
50ヲthethirdα四helicaldomain extending from aa 56 to aa 77う thearginine rich region 
extending frOln aa 77 to 96うandleucine zipper-like domain extending frOln aa 60 to aa 
81. 
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Fi伊1・e3. Schematic representation of pre-mRNA splicing and the spliceosome 
assembly pathway. Splicing is an essential step of gene expression in which introns are 
relnoved fi-01n pre-mRNA to generate nlature lnRNA that can be translated by the 
ribos01ne. This reaction is catalyzed by a large and dynmnic nlacronloIecular RNP 
c01nplex called the spliceoso111e. The spliceosome is fo1'med by the stepwise integration 
of five snRNPs composed of U 1， U2ヲ U4ラ U5ラ andU6 snRNAs and 1110re than 50 
proteins binding sequentially to pre-lnRNA. 
ln the earl y stepぅUlsn又NP(yellow circle) binds to 5ラsplicesite of pre-nlRNAラ
yielding complex E. SpliceosOlne fonnation initially involves the interaction of U 1 and 
U2 (blue circle) snRNPs with the 5'splice site and the branch site (red)ぅ respectivel yラ
yielding the PI・e-spliceosome01' c01nplex A. The U4/5/6 tri-snRNP (g1'ay circles)ラ 11
which U4 and U6 snRNAs are base畑paredヲ isthen stably bound to give cOlnplex B. 
whichぅhoweverヲstilhas no catalytic center. For catalytic activation of the spliceosonleラ
c0I1plex B undel・goesa dranlatic structural change that involves the dissociation of the 
intermolecular U4-U6 RNA helices and the fOTI11ation of al1 intricate l1etwor1正 of
interactions between the U6う U2，and pre-mRNA 11101eculesぅwhichtogether constitute 
part of the catalytic core of the spliceosOlne. Prior to this RNA rearrangenlentラ Ul
snRNP has to dissociate f1'o11 the Y splice sIte. The activated cOll1plex B undergoes the 
first catalytic step of splicingぅwhichgenerates cOl11plex C. Complex C undergoes the 
second catal ytic step after which the post-spliceos0111al intron-containing cOl11plex is 
dismantled and l11RNA product is released (Stark and LuhTI11annラ 2006).SAP 1 45ラ
SAP49 and U2B" are cOl11ponents of SF3b in U2 snRNP. U 1-70K is a conlponent of U 1 
snRNP. U2AF65 and U2AF/35 are splicing factors. 
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⑭ 
Complex 
E 
A 
B 
C 
Fi忠11・e4. Vpr interacted with SAP145 in vitro and in vivo・(A)GST pull-downs were 
perfonned with 35S-labeledラinvitro translated SAP 145 and 100 pmol of GST (lane 2) 01・
10ラ 30， 100 plnol of GST-Vpr (l凱1es 3ラ 4 and 5) respecti vel y. 
Glutathione-Sepharose-precipitated proteins or 2010 of input SAP 145 (lane 1) were 
analyzed by 60/0 SDS-PAGE gels and visualized by autoradiography. (B) Extracts frOlTI 
HeLa cells transfected either without (Mock) or with pME18Neo encoding Flag-tagged 
Vpr (pME 18Neo-FVpr) transiently and immunoprecipitated with ll10use prein1n1une IgG， 
anti-FLAG M2 MAbラoranti-SAP 145 antibody. Bound proteins and 2.501<) of the extract 
(Input) were subjected to Western blot analysis with anti-FLAG M2 MAb. 
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Figure 4 
噂繭闘惨
Figure 5. Vpr colocalized with SAP145 in the nucleus. HeLa cells that were 
transiently transfected with pME18Neo-FVpr were stained with anti-FLAG M2 MAb 
(1eft panel) together with anti-SAP145 serum (n1iddle panel)ラ andthen cells were 
analyzed by confocal laser scanning 11icI・oscopy.Bar， 10μlTI. The fields were lnerged 
(right panel) to show colocalization (aITo¥νheads) in yellow. 
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Fi忠汀e6. Vpr was associated ¥vith other spliceosomal proteins. Extract frol1 HeLa 
cells transiently transfected with pME18Neo-FVpr (Vpr) or with the contr叶 vector
pME18Neo (Cont.). At 24 h after transfectionう cells were subjected to 
UTIlTIunoprecipitation with anti-FLAG M2 MAbラ anti-SAP145ラ anti-SAP49う
anti目Ul-70KserUlll or anti-U2B" MAb. The blot was probed with anti-FLAG M2 MAb. 
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Figure 7. Vpr was associated with Ul and U2snRNPs. GST puIトdownswere 
perfonned with nuclear extract (NE)合on1HeLa cells under splicing conditions in a 
五na]volU1ne of 50 JlI in the presence of 2.5 mnol of the GST or GST-Vpr. 
Glutathione-Sepharose-precipitated RNA and 2% of input NE (Input) were analyzed by 
denaturing polyacl・ylan1idegels. The blot was probed with the U 1 or U2 snIミNA
riboprobe. 
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Figure 8. Vpr existed in the spliceosome. HeLa cels that were transiently transfected 
¥vith pME18Neo-FVpr were stained with anti四FLAGM2 MAb (left panel) together with 
anti-SC35 antibody (middle panel)ぅ andthen cels were anaIyzed by confocal laser 
scanning nlicroscopy. Bar， 10μm. The fields were lnerged (right panel) to show 
colocalization (arrow heads) in yellow. 
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Figure 9. Vpr inhibited野田globinsplicing in vitro. NE was prepared fron1 transfected 
HeLa cells with either without (Mock) or with pME18Neo-FVpr (Vpr) transiently. 
32P-Labeled s-globin pre-lnRNA was incubated for 2 h at30 oC with NE frol1 HeLa-S3 
cells with (lane 2) or without energy (ATP/CP) (lane 1)ぅandin the indicated an10unts of 
Mock NE (lanes 3ラ4and 5; 4ラ 12and 20μg respectively) or Vpr-containing NE (lanes 6ラ
7 and 8; 4ラ 12and 20μg respectively) were added. The RNA products were separated 
on a 70/0 polyacrylan1ide-7 M urea denaturing gel and the bands were visua1ized by 
autoradiography. Splicing efficiencies of s-globin p吟 lnRNAswere quantified by using 
a BAS2500. Splicing activity was taken to be the product of 
n1RNA/(pr・e-lnRNA十lnRNA)X 100ラandrelative splicing was taken to be the product of 
each splicing activity/control splicing activity X 100. All experin1ents were done at least 
three times. Average splicing efficiencies and standard deviations are shown. 
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Fi忠lre10. Analysis of spliceosome formation in Vpr-containing extracts. 1n vitro 
splicing reactions were perfon11ed in Mock NE (Mock) or Vpr-containing NE (Vp1') 
using 32P-labeled s-glohin pre-lnRNA as substrate. At indicated tIlne points (0ラ 30and 
60 lnin) san1ples were withdrawn and directly analyzed fo1' spliceosolne fonnation using 
native 4.20/0 polyacrylalnide gel electrophoresis and yisualized by autoradiography. 
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Fi忠1・e11. Vpr mutants accumulated a同globin2 pre四mRNA.Schelnatic presentation 
of the predicted first α-helical dOlnain (α-Helix 1)ぅsecondα-helical dOlnain (α-Helix2)， 
the third u-helical dOlnain (α-Helix3) as well as the arginine rich regiol1 of Vpl・protein
are indicated. Grey areas represent the FLAG山tagand GFP-tag. The resu1ts of 
a-globin 2 pl・e-n1RNAaccu111ulation by Vpr l11utants are SUn1111aI立ed(right panel). 
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Figure 12. Construction of point mutant(s) Vpr proteins. The lnutations introduced 
wi thin the thirdα山helicaldOlnain (α-Helix3) and Arginine rich region of Vpr protein. 
The diagran1 shows schematic representations of the various proteins and putative 
d0111ains. Grey areas show the FLAG-tag. It was naIned replacing that the Leucine at 
position 67 by Prolineラ L67Pう theArginine at position 80 or 88 by Alanineラ R80Aor 
R88Aラrespectivel y. 
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Figure 13. Several Vpr mutants are decreased in binding to SAP145. Extracts合01l
HeLa cells were transfected transiently with pME18NeかFVprラ Vpr/L67Pラ VprlR80Aラ
Vpr/R88AラVpr/L67P/R80Aor Vpr/L67P/R88A， or with the control vector pME18Neo. 
At 24 h after transfectionラ cells were subjected to in11llunoprecipitation with 
antI-SAP 145 serum. Bound proteins (upper panel) and 5% of the extract (Inputラ lower
panel) were subjected to Western blot analysis with anti時FLAGM2MAb. 
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Figure 14. Vpr mutants with decreased binding to SAP145 were restored in vitro 
splicing activity. 1n vitro splicing reactions were perf01111ed in NE fro11 HeLa cells with 
the control vector pME18Neo (Cont.) or NE of transfected cells with pME18Neo-FVpr 
Vpr/L67PラVpr/R80AぅVprlR88AラVpr/L67P/R80Aor Vpr/L67P/R88A using 32p目labeled
s-globin PI・e-l11RNAラ assubstrate. The RN A pl・oductswere separated on a 70/0 
polyacrylaI11ide-7 M urea denaturing polyacrylaI11ide gel electrophoresis and visua1ized 
by autoradiography (upper panel). The NE used for in vitl句 splicingwas subsequently 
subjected to Western blot analysis with anti-FLAG M2 MAb (lnputラlowerpanel). 
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Figure 15. Vpr inhibits the interaction between SAP145 and SAP49. (A) Extracts 
合011HeLa cells transiently with pME 18Neo-FVpr (十)or with the cOl1trol vector 
pME18Neo (-)ラ werein1111UnOprecipitated with anti-FLAG M2 MAb or anti-SAP 145 
antibody. The bound proteins and 5% of extract (Input) were subjected to Western blot 
analysis with anti目SAP49antiserun1. (B) Extracts frOln HeLa cells transfected with 
contI・01vector pME18Neo (Cont.) or with pME18Neo-FVpr， Vpr/L67Pう Vpr/R80Aラ
VprlR88Aラ Vpr/L67P/R80A or Vpr/L67P/R88A were IlnlnunopI・ecipitated with 
anti-SAP145 antibody and analyzed by 8% SDS】PAGEge1s. The bound proteins (upper 
panel) and 50/0 of the extract (Inputう lniddlepanel) were analyzed with anti-SAP49 
antibody or anti-FLAG M2 MAb (Inputうlowerpanel). 
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Figure 16. Vpr inhibits with SAP49 for formation of SAP49田SAP145complex. 
j)S-labeled in vitro translated SAP49ラnon句labelediηvitro translated SAP 145 and GST 
(10 and 100 plnolラ respectively)or GST-Vpr protein (10 and 100 p11101ラ respectively)
were 111ixed and i1111nUnOprecipitated with anti-SAP 145 antiserun1 and protein 
A-Sepharose. In11nunoprecipitated proteins or 2% of input SAP49 (Input) were analyzed 
by 8010 SDS-PAGE gels and visualized by autoradiography (upper panel). 
hnn1unoprecipitation without GST and GST-Vpr was perfonned as a control. The band 
signal intensity was句uantifiedby using a BAS2500 and the intensities of bands were 
l10nnalized with that ofthe control (lower panel). 
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Figure 17. The Three田dimensionalstructure of SF3b. The Three-dunensional 
reconstruction of the lnultiple protein cOlnplexes SF3b at ~ 10 A resolution by 
single-particle electron cryOlnIcroscopy (Golas et al.ラ2003).Two RRMs belonging to 
the SAP49 could be identified clearly (green). 
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Figure 18. A model for inhibitory mechanism of splicing reaction by Vpr in the 
P-globin pre四mRNA.Vpr interacts with SAP 145 resulting in the suppression of direct 
interaction between SAP 145 and SAP49. Since SAP49 interacts directly and highly 
specifical1y with both SAP 145 and pre-lnRNA in essential splicing factor SF3bラbinding
of the U2 snRNP to pre-mRNA lnight be reduced. At the ear匂 stagesof spliceosolne 
assen1bly， the reduction， decrease of SAP 145・SAP49cOlnplex lnay suppress that 
cOlnplex A changes to complex B (C01nplex A， right side). Thusラ splicingreaction is 
inhibited by Vpr. 
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γable 1. Characteristics of Vpr 
Virus related 
Viriorトassociatedprotein 
iηcorporation into the virus particles 
Transcriptional activator 
Effect on virus replication 
75 
Cellular level 
しocalizesin the nucleus 
Cell cycle arrest at the G2 stage 
Apoptosis 
Oligomerization 
Table 2. I nteracting Partners and characteristics of Vpr 
Cellular proteins 
Importinα 
Pom 121 
14-3-3 
ANT 
CyclinT1 
HHR23A 
P34mov 
Lysine tRNA synthetase 
TFIIB 
Sp1 
GRII 
Biological significance of the interaction 
Nuclear translocation of the汁IVぺPIC
and nuclear localization of Vpr 
Localizes in the nucleus 
Cell cycle arrest at the G2 stage 
Apoptosis 
Transactivation 
Cell cycle arrest at the G2 stage and 
apoptosis (?) 
Cell cycle arrest at the G2 stage (?) 
HIV-1 reverse transcription 
Transactivation of promoter 
Transactivation of the HIV-1 L TR 
Transactivation of the glucoco吋icoid-
Responsive promoter 
? = has been controversial evidence. 
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